卵巢癌患者临终关怀中的种族与民族差异
基于德克萨斯州癌症登记-医疗保险数据,评估2000至2012年死亡的卵巢癌患者临终关怀差异。共纳入3666例,西班牙裔和黑人患者较白人更少入组并死于临终关怀机构,西班牙裔更易入ICU,黑人更易多次急诊就诊和接受生命延长操作。
要点
- 西班牙裔和黑人患者较白人更少入组并死于临终关怀机构。
- 西班牙裔患者更易在生命最后30天入ICU。
- 黑人患者更易多次急诊就诊和接受生命延长操作。
核心结论
- 研究发现少数族裔卵巢癌患者与接受密集和侵入性临终关怀相关。
研究设计与样本
- 使用德克萨斯州癌症登记-医疗保险数据,评估2000至2012年死亡且死亡前有至少13个月连续医疗保险覆盖的卵巢癌患者,共3666例,其中白人2819例(77%)、西班牙裔553例(15%)、黑人256例(7%)、其他38例(1%)。
主要发现
- 2642例(72%)在死亡前入组临终关怀,但仅2344例(64%)在入组期间死亡,临终关怀入组中位持续时间为20天。
- 生命最后30天内,381例(10%)有超过1次急诊就诊,505例(14%)有超过1次住院,593例(16%)入ICU,848例(23%)接受侵入性护理,418例(11%)接受生命延长护理。
- 生命最后14天内,357例(10%)接受化疗。
- 西班牙裔和黑人患者较白人更少入组并死于临终关怀机构(黑人OR 0.66,95%CI 0.50至0.88,P=0.004;西班牙裔OR 0.76,95%CI 0.61至0.94,P=0.01)。
- 西班牙裔患者更易入ICU(OR 1.37,95%CI 1.05至1.78,P=0.02),黑人患者更易有超过1次急诊就诊(OR 2.20,95%CI 1.53至3.16,P<0.001)和接受生命延长操作(OR 2.13,95%CI 1.49至3.04,P<0.001)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Purpose To assess disparities in end-of-life care among patients with ovarian cancer. Patients and Methods Using Texas Cancer Registry-Medicare data, we assessed patients with ovarian cancer deceased in 2000 to 2012 with at least 13 months of continuous Medicare coverage before death. Descriptive statistics and multivariate logistic regressions were conducted to evaluate end-of-life care, including chemotherapy in the final 14 days of life, intensive care unit (ICU) admission in the final 30 days of life, more than one emergency room (ER) or hospital admission in the final 30 days of life, invasive or life-extending procedures in the final 30 days of life, enrollment in hospice, enrollment in hospice during the final 3 days of life, and enrollment in hospice while not hospitalized. Results A total of 3,666 patients were assessed: 2,819 (77%) were white, 553 (15%) Hispanic, 256 (7%) black, and 38 (1%) other. A total of 2,642 (72%) enrolled in hospice before death, but only 2,344 (64%) died while enrolled. The median hospice enrollment duration was 20 days. In the final 30 days of life, 381 (10%) had more than one ER visit, 505 (14%) more than one hospital admission, 593 (16%) ICU admission, 848 (23%) invasive care, and 418 (11%) life-extending care. In the final 14 days of life, 357 (10%) received chemotherapy. Several outcomes differed for minorities compared with white patients. Hispanic and black patients were less likely to enroll and die in hospice (black odds ratio [OR], 0.66; 95% CI, 0.50 to 0.88; P = .004; Hispanic OR, 0.76; 95% CI, 0.61 to 0.94; P = .01). Hispanic patients were more likely to be admitted to an ICU (OR, 1.37; 95% CI, 1.05 to 1.78; P = .02), and black patients were more likely to have more than one ER visit (OR, 2.20; 95% CI, 1.53 to 3.16; P < .001) and receive a life-extending procedure (OR, 2.13; 95% CI, 1.49 to 3.04; P < .001). Conclusion We found being a minority was associated with receiving intensive and invasive end-of-life care among patients with ovarian cancer.
引用
- Taylor JS, Rajan SS, Zhang N, et al. End-of-Life Racial and Ethnic Disparities Among Patients With Ovarian Cancer. J Clin Oncol. 2017. PMID: 28388292. doi:10.1200/JCO.2016.70.2894
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。